TDCS Stimulation After Covid-19 Infection

Recruiting now · Not applicable · Has a placebo group

Conditions studied: COVID-19

In brief

In this study, the effects of bilateral stimulation of the dorsolateral prefrontal cortex (DLPFC) with active tDCS (transcranial direct stimulation/transcranial direct stimulation) on neurocognitive (memory and executive) functions in patients with Covid-19 infection and subjective cognitive complaints, as well as resting-state fMRI In the case of dfMRI, it is aimed to examine the default mode network (DMN) and parietal memory network (PMN) inter- and intra-network connectivity alterations and the hippocampal region connectivity alterations and contribute to the relevant literature.

Key facts

Study ID

NCT06183424

Run by

Istanbul Medipol University Hospital

People needed

50

Starts

2023-10-01

Expected to finish

2025-12-01

Last updated by the study team

2025-05-02

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Have received a positive value from the COVID-19 RT-PCR test in the last 60 days and turned negative
• Being between the ages of 18-50
• 21 days have passed since the disease onset date

You may not qualify if…

• Having any neurological or psychiatric disease

Where it is running

• Alanya Alaaddin Keykubat Üniversitesi — Antalya, Turkey (Türkiye) (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.